302 Using the 21-gene Breast Cancer Assay in Adjuvant Decision-making in ER-positive (ER+) Early Breast Cancer (EBC) is Cost-effective: Results of a Large Prospective German Multicenter Study

✍ Scribed by W. Eiermann; M. Rezai; S. Kummel; T. Kuhn; M. Warm; K. Friedrichs; A. Benkow; J. Blohmer

• Book ID: 117662210
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 59 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(12)70368-4